Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares RepurchasedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cryo Cell International (CCEL) Long-Term Debt Repayments (2016 - 2025)

Cryo Cell International (CCEL) has disclosed Long-Term Debt Repayments for 11 consecutive years, with $37340.0 as the latest value for Q4 2025.

  • On a quarterly basis, Long-Term Debt Repayments rose 24.66% to $37340.0 in Q4 2025 year-over-year; TTM through Nov 2025 was $147575.0, a 8.21% increase, with the full-year FY2025 number at $147575.0, up 8.21% from a year prior.
  • Long-Term Debt Repayments was $37340.0 for Q4 2025 at Cryo Cell International, up from $35819.0 in the prior quarter.
  • In the past five years, Long-Term Debt Repayments ranged from a high of $1.8 million in Q1 2021 to a low of $28058.0 in Q3 2024.
  • A 5-year average of $324365.4 and a median of $40601.5 in 2023 define the central range for Long-Term Debt Repayments.
  • Peak YoY movement for Long-Term Debt Repayments: soared 129.03% in 2021, then tumbled 96.17% in 2023.
  • Cryo Cell International's Long-Term Debt Repayments stood at $775000.0 in 2021, then crashed by 95.02% to $38563.0 in 2022, then rose by 5.45% to $40665.0 in 2023, then dropped by 26.34% to $29954.0 in 2024, then grew by 24.66% to $37340.0 in 2025.
  • Per Business Quant, the three most recent readings for CCEL's Long-Term Debt Repayments are $37340.0 (Q4 2025), $35819.0 (Q3 2025), and $40538.0 (Q2 2025).